Lucintel Blog: Lucintel Forecasts Microbiome Sequencing Market to Grow at a CAGR of 17%-19%

Thursday, December 16, 2021

Lucintel Forecasts Microbiome Sequencing Market to Grow at a CAGR of 17%-19%

According to the recent study the microbiome sequencing market is projected to grow at a CAGR of 17%-19% from 2020 to 2025. Growth in this market is primarily driven by increasing focus on human microbiome therapy, rising government initiatives for microbiome research, and growing research activities for early disease diagnosis.

Browse XX figures / charts and XX tables in this 150-page report to understand trends, opportunities and forecast in microbiome sequencing market by technology (sanger sequencing, high-throughput sequencing (SBS, SBL, shotgun sequencing, TGS, RNA sequencing, WGS, and others), and third-generation sequencing), component (reagents & kits and instruments (liquid handling instruments, cytometers, imaging devices, and microplate reader)), application (drug discovery, genetic screening, disease diagnosis research, personalized medicine, and others), laboratory type (dry labs and wet labs), end user (pharmaceutical & biotechnology, academic centers & research institutes, contract research organizations, and others), and region (North America, Europe, Asia Pacific, and Rest of the World).

Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/microbiome-sequencing-market.aspx

“Sanger sequencing market is expected to remain the largest segment during the forecast period.”

Based on sequencing technology, the microbiome sequencing market is segmented into sanger sequencing, high-throughput sequencing (SBS, SBL, shotgun sequencing, TGS, RNA sequencing, WGS, and others), and third-generation sequencing. Lucintel forecasts that the sanger sequencing market is expected to remain the largest segment during the forecast period as it is preferred more by researchers because of higher accuracy than other technologies.

“Within the microbiome sequencing market, the pharmaceutical and biotechnology companies segment is expected to remain the largest end user.”

Based on end user, the pharmaceutical and biotechnology companies segment is expected to witness the largest segment over the forecast period due to increasing prevalence of cancer and increasing demand for personalized genomics.

“North America will dominate the microbiome sequencing market in near future.”

North America is expected to be the highest growth over the forecast period over the forecast period due to rising research actives related to genomics, surge in number of research studies on cancer & inherited rare diseases, and increasing government support related to microbiome sequencing in the region.

Download Brochure of this report by clicking on https://www.lucintel.com/microbiome-sequencing-market.aspx

Major players of microbiome sequencing market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Thermo Fisher Scientific, Illumina, Qiagen, Molzym, Novogene, Allele, Baseclear, BGI, Biolog, and Biomathematica are among the major microbiome sequencing providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/microbiome-sequencing-market.aspx or helpdesk@lucintel.com

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751